Income Statement - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | ||
| Cost of revenue | 0.61 | ||||
| Gross profit | -0.61 | ||||
| Total operating expenses | 145.82 | 80.86 | 64.77 | 0.00 | 0.04 |
| Operating income | -145.82 | -80.86 | -64.77 | 0.00 | -0.04 |
| Non-operating income (net) | 11.78 | 6.59 | 0.07 | 0.00 | 0.00 |
| Income before tax | -134.04 | -74.28 | -64.70 | 0.00 | -0.04 |
| Net income | -134.04 | -74.28 | -64.70 | 0.00 | -0.04 |
Show Quarterly Income Statement
Income Statement - BridgeBio Oncology Therapeutics, Inc. (BBOT)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Cost of revenue | 0.19 | 0.19 | 0.16 | ||||||||
| Gross profit | -0.19 | -0.19 | -0.16 | ||||||||
| Total operating expenses | 45.99 | 43.41 | 49.18 | 30.09 | 23.14 | 21.88 | 19.66 | 23.87 | 15.45 | 0.04 | 0.00 |
| Operating income | -46.18 | -43.41 | -49.18 | -30.09 | -23.14 | -21.88 | -19.66 | -23.87 | -15.45 | -0.04 | 0.00 |
| Non-operating income (net) | 4.07 | 4.61 | 4.42 | 1.66 | 1.08 | 2.19 | 2.34 | 2.05 | 0.01 | 0.00 | 0.00 |
| Income before tax | -42.11 | -38.80 | -44.76 | -28.44 | -22.06 | -19.69 | -17.32 | -21.82 | -15.44 | -0.04 | 0.00 |
| Net income | -42.11 | -38.80 | -44.76 | -28.44 | -22.06 | -19.69 | -17.32 | -21.82 | -15.44 | -0.04 | 0.00 |